Pregnancy Outcomes following Systemic Prenatal Acyclovir Exposure: Conclusions from the International Acyclovir Pregnancy Registry, 1984-1999

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 4, 2004, Pages 201-207

  Stone, Katherine M ^a   Reiff Eldridge, Robbin ^b   White, Alice D ^b   Cordero, José F ^c   Brown, Zane ^d   Alexander, E Russell ^d   Andrews, Elizabeth B ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b GLAXOSMITHKLINE   (United States)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Acyclovir treatment; Genital herpes; HSV; Pregnancy

Indexed keywords

ACICLOVIR;

ADULT; ARTICLE; ASCITES; BIRTH DEFECT; BLINDNESS; CLEFT PALATE; CLINICAL TRIAL; DIAPHRAGM HERNIA; FEMALE; FETOTOXICITY; FETUS RISK; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GENITAL HERPES; HEALTH SURVEY; HEMANGIOMA; HERPES VIRUS INFECTION; HIP DYSPLASIA; HUMAN; INDUCED ABORTION; INFANT; INTERNATIONAL COOPERATION; JOINT MALFORMATION; LIMB DEFORMITY; MAJOR CLINICAL STUDY; MICROGNATHIA; MULTICENTER STUDY; NEURAL TUBE DEFECT; OUTCOMES RESEARCH; POPULATION RESEARCH; PREGNANCY COMPLICATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUBLICATION; PYLORUS STENOSIS; QUESTIONNAIRE; REGISTER; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE; STILLBIRTH; THIRD TRIMESTER PREGNANCY;

ABNORMALITIES, DRUG-INDUCED; ACYCLOVIR; ANTIVIRAL AGENTS; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY OUTCOME;

HERPESVIRIDAE;

EID: 2342559854     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.20013     Document Type: Article

References (34)

1. AAP. 1997. Herpes simplex. In: Peter F, editor. Red book: 1997 report of the Committee on Infectious Diseases. 24th edition. Elk Grove Village, IL: American Academy of Pediatrics. pp. 266-276.
2. AAP. 2003. Herpes simplex. In: Pickering LK, editor. Red book: 2003 report of the Committee on Infectious Diseases. 26th edition. Elk Grove Village, IL: American Academy of Pediatrics. pp. 344-353.
3. ACOG. 2000. Management of herpes in pregnancy: Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 68:165-173.
4. Andrews EB, Tilson HH. 1988. Acyclovir in pregnancy registry: an observational epidemiologic approach. Am J Med 85(suppl 2A):123-128.
5. Andrews EB, Yankaskas BC, Cordero JF, et al. 1992. Acyclovir in Pregnancy Registry: six years' experience. Obstet Gynecol 79:7-13.
6. Applegate MS, Druschel CM. 1995. The epidemiology of infantile hypertrophic pyloric stenosis in New York State: 1983 to 1990. Arch Pediatr Adolesc Med 149:1123-1124.
7. Brown Z, Baker DA. 1989. Acyclovir therapy during pregnancy. Obstet Gynecol 73:526-531.
8. Brown Z, Selke S, Zeh J, et al. 1997. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 337:509-515.
9. Brown ZA, Vontver LA, Benedetti J, et al. 1987. Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 317:1246-1251.
10. Brown ZA, Wald A, Morrow RA, et al. 2003. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289:203-209.
11. CDC. 1989. Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 38(suppl 8):1-43.
12. CDC. 1993a. Pregnancy outcomes following systemic prenatal acyclovir exposure: June 1, 1984-June 30, 1993. Centers for Disease Control and Prevention. MMWR 42:806-809
13. CDC. 1993b. 1993 Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. MMWR Recomm Rep 42:1-102.
14. CDC. 1998a. Metropolitan Atlanta Congenital Defects Program procedure manual. Atlanta: Centers for Disease Control and Prevention.
15. CDC. 1998b. 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Recomm Rep 47:1-111.
16. CDC. 2002. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 51:1-78.
17. Fleiss JL. 1981. Statistical methods for rates and proportions. New York: John Wiley and Sons. p. 14-15.
18. Frenkel LM, Brown ZA, Bryson JY, et al. 1991. Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol 164:569-576.
19. Gutierrez KM, Halpern MSF, Maldonado Y, Arvin A. 1999. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis 180:199-202.
20. Honein MA, Paulozz LJ, Himelright IM, et al. 1999a. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet 354:2101-2105.
21. Honein MA, Paulozzi LJ, Cragan JD, Correa A. 1999b. Evaluation of selected characteristics of pregnancy drug registries. Teratology 60:356-364.
22. Jedd MB, Melton LJ, Griffin MR, et al. 1988. Trends in infantile hypertrophic pyloric stenosis in Olmsted County, Minnesota, 1950-1984. Paediatr Perinat Epidemiol 2:148-157.
23. Johnson RE, Mullooly JP, Valanis BG, et al. 1990. Acyclovir use and its surveillance in a general population. Drug Intell Clin Pharm 24:624-628.
24. Kline J, Stern Z, Susser M. 1989. Conception to birth. Epidemiology of prenatal development. Oxford: Oxford University Press. p. 43-68.
25. Moore HL, Szczech GM, Rodwell DE, et al. 1983. Preclinical toxicology studies with acyclovir: teratologic, reproductive, and neonatal tests. Fundam Appl Toxicol 3:560-568.
26. Prober CG, Corey L, Brown ZA, et al. 1992. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis 15:1031-1038.
27. Randolph AG, Washington AE, Prober CG. 1993. Cesarean delivery for women presenting with genital herpes lesions: efficacy, risks, and costs. JAMA 270:77-82.
28. Reiff-Eldridge R, Heffner CR, Ephross SA, et al. 2000. Monitoring pregnancy outcomes following prenatal drug exposure through prospective registries: a pharmaceutical company commitment. Am J Obstet Gynecol 182:159-163.
29. Scott LL, Sanchez PJ, Jackson GL, et al. 1996. Acyclovir suppression to prevent cesarean delivery after first episode genital herpes. Obstet Gynecol 87:69-73.
30. Scott LL, Alexander J. 1998. Cost-effectiveness of acyclovir suppression to prevent recurrent genital herpes in term pregnancy. Am J Perinatol 15:57-62.
31. Scott LL, Hollier LM, McIntire D, et al. 2002. Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect Dis Obstet Gynecol 10:71-77.
32. Stahlmann R, Klug S, Lewandowski C, et al. 1988. Prenatal toxicity of acyclovir in rats. Arch Toxicol 61:468-479.
33. Stone KM, Brooks CA, Guinan ME, Alexander ER. 1989. National surveillance for neonatal herpes simplex virus infections. Sex Transm Dis 16:152-156.
34. Whitley RJ, Corey L, Arvin A, et al. 1988. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 158:109-116.